Tag
A new Nature study led by Monash University's Devon Stoliker challenges the idea that psychedelics simply create chaos in the brain, using AI analysis of MRI and EEG scans from psilocybin sessions to reveal structured changes in brain network connectivity that may underlie meaningful, insightful experiences.
Australia achieved a world-first breakthrough by allowing MDMA and psilocybin for psychiatric treatment, and this podcast episode explores how it happened and lessons for other countries.
A large neuroimaging study published in Nature found that psilocybin creates hidden order in brain activity, making neural signals clearer during psychedelic experiences, which could enhance psychedelic therapy by emphasizing context and environment.
Early clinical trial results suggest psilocybin, the active ingredient in magic mushrooms, could kick-start recovery in anorexia patients, offering a potential new treatment for a disorder with high mortality and limited effective therapies.
This case report documents transient multidomain functional improvements in an advanced Alzheimer's patient following high-dose psilocybin administration, with recovery of speech, continence, and social interaction over days to weeks.